Mild Cognitive IMpairment

Research Study


Have you or a loved one had a recent change in memory? 

A lot of people attribute forgetfulness and memory impairment to "just getting older." But the truth is there may be many factors that contribute to losing your train of thought or misplacing things frequently. 

Local doctors are studying an investigational drug for memory impairment due to early stages of Alzheimer's disease. If you or a loved one are experiencing memory loss, or are taking memantine, donepezil, or rivastigmine,  you may qualify for this research study.

In order to qualify for this study, participants must: 

  • Be between the ages of 50-85 years old 
  • Are experiencing mild cognitive impairment due to Alzheimer's Disease (AD) or mild AD dementia 
  • Have impaired episodic memory
  • Be able to provide written informed consent

.Study-related care and medication may be provided at no cost to qualified participants.  Qualified participants may be compensated for time and travel. 

Please fill out this brief survey below, and a Study Coordinator will get back to you.

Name *
Name
Phone *
Phone
Are you at between the ages of 50-85? *
Are you experiencing mild cognitive impairment due to Alzheimer's Disease (AD) or mild AD dementia? *
Are you willing and able to provide written informed consent for participation? *
Do you have impaired episodic memory? *